Aldagen (ALDH) Files $80.5M IPO
Tweet Send to a Friend
Aldagen (Nasdaq: ALDH) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $80.5 million. The company plans to list on the NASDAQ under the stock symbol "ALDH".
The offering is being made through Cowen and Company, Wachovia Securities and Pacific Growth Equities.
Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. [BCS]
The offering is being made through Cowen and Company, Wachovia Securities and Pacific Growth Equities.
Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. [BCS]
You May Also Be Interested In
- Tremor Video (TRMR) Files $86.25M IPO
- Alcobra (ADHD) IPO Trades Lower
- PTC Therapeutics (PCTC) Files $85M IPO
Create E-mail Alert Related Categories
IPOsRelated Entities
Wachovia
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
